Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GREB1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
mRNA | PGRMC2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
mRNA | GPRIN3 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0008 |
mRNA | TAF2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
mRNA | CSNK2A3 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0008 |
mRNA | UBE2N | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
mRNA | TTC33 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
mRNA | CSNK1G1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0008 |
mRNA | DBP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
mRNA | FBXO41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |